THERESA PAYNE: Open Payments
NPI 1083705909 · RANCHO MIRAGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 22 payments from 8 companies in 2025. Trend: 2023 $1,655 · 2024 $85 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $164 |
| Ardelyx, Inc. | 3 | $154 |
| Mallinckrodt Hospital Products Inc. | 5 | $105 |
| Vifor Pharma, Inc. | 3 | $70 |
| Calliditas Therapeutics US Inc. | 2 | $54 |
| Apellis Pharmaceuticals, Inc. | 2 | $45 |
| OPKO Pharmaceuticals, LLC | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
Products named: XPHOZAH 30 MG, ACTHAR, Veltassa, TARPEYO, Empaveli, LOKELMA, FARXIGA, IBSRELA.
Industry payments across CA — which companies pay providers there.
